Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-23-005176

Options or other derivatives

  • Chief Scientific Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hunt Hazel Chief Scientific Officer 2023-02-13 Grant or award · Stock option (right to buy) +200,000 200,000 D
Loading xslF345X03/doc4.xml…